BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26280465)

  • 1. Incomplete erythropoietic protoporphyria caused by a splice site modulator homozygous IVS3-48C polymorphism in the ferrochelatase gene.
    Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
    Br J Dermatol; 2016 Jan; 174(1):172-5. PubMed ID: 26280465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Mutation in the FECH Gene in a Czech Family with Erythropoietic Protoporphyria and a Population Study of IVS3-48C Variant Contributing to the Disease.
    Farrag MS; Kučerová J; Šlachtová L; Šeda O; Šperl J; Martásek P
    Folia Biol (Praha); 2015; 61(6):227-32. PubMed ID: 26789144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, biochemical, and genetic study of 11 patients with erythropoietic protoporphyria including one with homozygous disease.
    Herrero C; To-Figueras J; Badenas C; Méndez M; Serrano P; Enríquez-Salamanca R; Lecha M
    Arch Dermatol; 2007 Sep; 143(9):1125-9. PubMed ID: 17875872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel splicing mutation and haplotype analysis of the FECH gene in a Chinese family with erythropoietic protoporphyria.
    Ma J; Xiao S; An J; Wang X; Xu Q; Dong Y; Feng Y; Wang J
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):726-9. PubMed ID: 19888946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inheritance in erythropoietic protoporphyria].
    Schmitt C; Ducamp S; Gouya L; Deybach JC; Puy H
    Pathol Biol (Paris); 2010 Oct; 58(5):372-80. PubMed ID: 20850938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietic Protoporphyria in a Japanese Population.
    Mizawa M; Makino T; Nakano H; Sawamura D; Shimizu T
    Acta Derm Venereol; 2019 Jun; 99(7):634-639. PubMed ID: 30938825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of erythropoietic protoporphyria in South Africa.
    Parker M; Corrigall AV; Hift RJ; Meissner PN
    Br J Dermatol; 2008 Jul; 159(1):182-91. PubMed ID: 18460026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and molecular diagnosis of erythropoietic protoporphyria in an Ashkenazi Jewish family.
    Schneider-Yin X; Mamet R; Minder EI; Schoenfeld N
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S363-7. PubMed ID: 18758989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic determinants of phenotype in North American patients with erythropoietic protoporphyria.
    Risheg H; Chen FP; Bloomer JR
    Mol Genet Metab; 2003; 80(1-2):196-206. PubMed ID: 14567969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations and phenotypic effect of the splice site modulator IVS3-48C in nine Swedish families with erythropoietic protoporphyria.
    Wiman A; Floderus Y; Harper P
    J Hum Genet; 2003; 48(2):70-6. PubMed ID: 12601550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
    Bloomer JR; Wang Y; Singhal A; Risheg H
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria.
    Gouya L; Martin-Schmitt C; Robreau AM; Austerlitz F; Da Silva V; Brun P; Simonin S; Lyoumi S; Grandchamp B; Beaumont C; Puy H; Deybach JC
    Am J Hum Genet; 2006 Jan; 78(1):2-14. PubMed ID: 16385445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular genetics of erythropoietic protoporphyria.
    Elder GH; Gouya L; Whatley SD; Puy H; Badminton MN; Deybach JC
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):118-26. PubMed ID: 19656460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of mutations in the ferrochelatase gene in Italian patients with erythropoietic protoporphyria.
    Aurizi C; Schneider-Yin X; Sorge F; Macrì A; Minder EI; Biolcati G
    Mol Genet Metab; 2007 Apr; 90(4):402-7. PubMed ID: 17196862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietic protoporphyria.
    Lecha M; Puy H; Deybach JC
    Orphanet J Rare Dis; 2009 Sep; 4():19. PubMed ID: 19744342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
    Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
    Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology of erythropoietic protoporphyria in the U.K.
    Whatley SD; Mason NG; Holme SA; Anstey AV; Elder GH; Badminton MN
    Br J Dermatol; 2010 Mar; 162(3):642-6. PubMed ID: 20105171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case of late-onset erythropoietic protoporphyria with myelodysplastic syndrome who has homozygous IVS3-48C polymorphism in the ferrochelatase gene.
    Suzuki H; Kikuchi K; Fukuhara N; Nakano H; Aiba S
    J Dermatol; 2017 Jun; 44(6):651-655. PubMed ID: 28026050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria.
    Kong XF; Ye J; Gao DY; Gong QM; Zhang DH; Lu ZM; Lu YM; Zhang XX
    J Hepatol; 2008 Feb; 48(2):375-9. PubMed ID: 18160121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron availability modulates aberrant splicing of ferrochelatase through the iron- and 2-oxoglutarate dependent dioxygenase Jmjd6 and U2AF(65.).
    Barman-Aksözen J; Béguin C; Dogar AM; Schneider-Yin X; Minder EI
    Blood Cells Mol Dis; 2013 Oct; 51(3):151-61. PubMed ID: 23787363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.